Longitudinal Analysis of Natural Killer Cells in Dengue Virus-Infected Patients in Comparison to Chikungunya and Chikungunya/Dengue Virus-Infected Patients

PLoS Neglected Tropical Diseases

Volumn 10, Issue 3, 2016, Pages

  Petitdemange, Caroline ^a,b   Wauquier, Nadia ^a,b,c   Devilliers, Hervé ^d   Yssel, Hans ^a   Mombo, Illich ^b   Caron, Mélanie ^b   Nkoghé, Dieudonné ^b   Debré, Patrice ^a   Leroy, Eric ^b   Vieillard, Vincent ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^c METABIOTA INC   (United States)

^d DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD57 ANTIGEN; GAMMA INTERFERON; GRANZYME B; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 18; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; PERFORIN;

ADULT; ARBOVIRUS; ARTICLE; CHIKUNGUNYA; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 2; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRINCIPAL COMPONENT ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; COMPLICATION; GABON; IMMUNOLOGY; LONGITUDINAL STUDY; MIXED INFECTION; PATHOLOGY;

ADULT; CHIKUNGUNYA FEVER; COINFECTION; DENGUE; FEMALE; GABON; HUMANS; KILLER CELLS, NATURAL; LONGITUDINAL STUDIES; MALE;

EID: 84962724284     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004499     Document Type: Article

References (47)

1. Halstead SB, Dengue. Lancet2007;370: 1644–1652. 17993365
2. Sam SS, Omar SF, Teoh BT, Abd-Jamil J, AbuBakar S, Review of Dengue hemorrhagic fever fatal cases seen among adults: a retrospective study. PLoS Negl Trop Dis2013; 7: e2194. doi: 10.1371/journal.pntd.000219423658849
3. Petitdemange C, Wauquier N, Vieillard V, Control of immunopathology during chikungunya virus infection. J Allergy Clin Immunol2015; 135: 846–855. doi: 10.1016/j.jaci.2015.01.03925843597
4. Caron M, Paupy C, Grard G, Becquart P, Mombo I, Nso BB, et al. Recent introduction and rapid dissemination of Chikungunya virus and Dengue virus serotype 2 associated with human and mosquito coinfections in Gabon, central Africa. Clin Infect Dis2012;55: e45–53. doi: 10.1093/cid/cis53022670036
5. Fredericks AC, Fernandez-Sesma A, The Burden of Dengue and Chikungunya Worldwide: Implications for the Southern United States and California. Ann Glob Health2014;80: 466–475. doi: 10.1016/j.aogh.2015.02.00625960096
6. Mustafa MS, Rasotgi V, Jain S, Gupta V, Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med J Armed Forces India2015;71: 67–70. doi: 10.1016/j.mjafi.2014.09.01125609867
7. Martina BE, Koraka P, Osterhaus AD, Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev2009;22: 564–581. doi: 10.1128/CMR.00035-0919822889
8. Gibbons RV, Kalanarooj S, Jarman RG, Nisalak A, Vaughn DW, Endy TP, et al. Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am J Trop Med Hyg2007;77: 910–913. 17984352
9. Simon F, Javelle E, Oliver M, Leparc-Goffart I, Marimoutou C, Chikungunya virus infection. Curr Infect Dis Rep2011;13: 218–228. doi: 10.1007/s11908-011-0180-121465340
10. Jost S, Altfeld M, Control of human viral infections by natural killer cells. Annu Rev Immunol2013;31: 163–194. doi: 10.1146/annurev-immunol-032712-10000123298212
11. Lanier LL, Evolutionary struggles between NK cells and viruses. Nat Rev Immunol2008;8: 259–268. doi: 10.1038/nri227618340344
12. Narni-Mancinelli E, Ugolini S, Vivier E, Tuning the threshold of natural killer cell responses. Curr Opin Immunol2013;25: 53–58. doi: 10.1016/j.coi.2012.11.00523270590
13. Campbell KS, Hasegawa J, Natural killer cell biology: an update and future directions. J Allergy Clin Immunol2013;132: 536–544. doi: 10.1016/j.jaci.2013.07.00623906377
14. Petitdemange C, Becquart P, Wauquier N, Béziat V, Debré P, Leroy EM, et al. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog2011;7: e1002268. doi: 10.1371/journal.ppat.100226821966274
15. Green S, Pichyangkul S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Nisalak A, et al. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis1999;180: 1429–1435. 10515800
16. Azeredo EL, Zagne SM, Santiago MA, Gouvea AS, Santana AA, Neves-Souza PC, et al. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology2001;204: 494–507. 11776403
17. Azeredo EL, De Oliveira-Pinto LM, Zagne SM, Cerqueira DI, Nogueira RM, Kubelka CF, NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin Exp Immunol2006;143: 345–356. 16412060
18. Beltrán D, López-Vergès S, NK Cells during Dengue Disease and Their Recognition of Dengue Virus-Infected cells. Front Immunol2014;5: 192. doi: 10.3389/fimmu.2014.0019224829565
19. Petitdemange C, Wauquier N, Rey J, Hervier B, Leroy E, Vieillard V, Control of acute dengue virus infection by natural killer cells. Front Immunol2014;5: 209. doi: 10.3389/fimmu.2014.0020924860571
20. Shresta S, Kyle JL, Robert Beatty P, Harris E, Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology2004;319: 262–273. 14980486
21. Malmberg KJ, Beziat V, Ljunggren HG, Spotlight on NKG2C and the human NK-cell response to CMV infection. Eur J Immunol2012;42: 3141–3145. doi: 10.1002/eji.20124305023255011
22. Béziat V, Descours B, Parizot C, Debré P, Vieillard V, NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS One2010;5: e11966. doi: 10.1371/journal.pone.001196620700504
23. Björkström NK, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson MA, et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood2010;116: 3853–3864. doi: 10.1182/blood-2010-04-28167520696944
24. Lopez-Vergès S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, et al. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood2010;116: 3865–3874. doi: 10.1182/blood-2010-04-28230120733159
25. Sturn A, Quackenbush J, Trajanoski Z, Genesis: cluster analysis of microarray data. Bioinformatics2002;18: 207–208. 11836235
26. Trapani JA, Smyth MJ, Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol2002;2: 735–74712360212
27. Moretta L, Montaldo E, Vacca P, Human natural killer cells: origin, receptors, function, and clinical applications. Int Arch Allergy Immunol2014;164: 253–264. doi: 10.1159/00036563225323661
28. Gumá M, Cabrera C, Erkizia I, Bofill M, Clotet B, Ruiz L, et al. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis2006;194: 38–41. 16741880
29. Björkström NK, Lindgren T, Stoltz M, Fauriat C, Braun M, Evander M, et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med2011;208: 13–21. doi: 10.1084/jem.2010076221173105
30. Béziat V, Dalgard O, Asselah T, Halfon P, Bedossa P, Boudifa A, et al. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol2012;42: 447–457. doi: 10.1002/eji.20114182622105371
31. Lopez-Vergès S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, et al. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A2011;108: 14725–14732doi: 10.1073/pnas.111090010821825173
32. Cannon MJ, Schmid DS, Hyde TB, Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol2010;20: 202–213. doi: 10.1002/rmv.65520564615
33. Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol2010;184: 5914–5927. doi: 10.4049/jimmunol.090025520404278
34. Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM, The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis2011;204: 115–123. doi: 10.1093/infdis/jiq00621628665
35. Djaoud Z, David G, Bressollette C, Willem C, Rettman P, Gagne K, et al. Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells. J Immunol2013;191: 2708–2716. doi: 10.4049/jimmunol.130113823918974
36. Petitdemange C, Wauquier N, Jacquet JM, Theodorou I, Leroy E, Vieillard V, Association of HLA class-I and inhibitory KIR genotypes in Gabonese patients infected by Chikungunya or Dengue type-2 viruses. PLoS One2014;9: e108798. doi: 10.1371/journal.pone.010879825264760
37. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature2011;476: 96–100. doi: 10.1038/nature1023721814282
38. Lobigs M, Müllbacher A, Regner M, MHC class I up-regulation by flaviviruses: Immune interaction with unknown advantage to host or pathogen. Immunol Cell Biol2003;81: 217–223. 12752686
39. Hershkovitz O, Zilka A, Bar-Ilan A, Abutbul S, Davidson A, Mazzon M, et al. Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells. J Virol2008;82: 7666–7676. doi: 10.1128/JVI.02274-0718508882
40. Cassidy SA, Cheent KS, Khakoo SI, Effects of Peptide on NK cell-mediated MHC I recognition. Front Immunol2014;5: 133. doi: 10.3389/fimmu.2014.0013324744756
41. Hershkovitz O, Rosental B, Rosenberg LA, Navarro-Sanchez ME, Jivov S, Zilka A, et al. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol2009;183: 2610–2621. doi: 10.4049/jimmunol.080280619635919
42. Baychelier F, Sennepin A, Ermonval M, Dorgham K, Debré P, Vieillard V, Identification of a cellular ligand for the natural cytotoxicity receptor NKp44. Blood2013;122: 2935–2942. doi: 10.1182/blood-2013-03-48905423958951
43. Grard G, Caron M, Mombo IM, Nkoghe D, Mboui Ondo S, et al. Zika virus in Gabon (Central Africa)—2007: a new threat from Aedes albopictus?PLoS Negl Trop Dis. 2014;8: e2681. doi: 10.1371/journal.pntd.000268124516683
44. Lwande OW, Obanda V, Bucht G, Mosomtai G, Otieno V, Ahlm C, et al. Global emergence of Alphaviruses that cause arthritis in humans. Infect Ecol Epidemiol. 2015;5: 29853. doi: 10.3402/iee.v5.2985326689654
45. Fauci AS, Morens DM, Zika Virus in the Americas—Yet Another Arbovirus Threat. N Engl J Med2016Jan13. [Epub ahead of print]
46. Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM, The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis2011;204: 115–123. doi: 10.1093/infdis/jiq00621628665
47. Pal T, Dutta SK, Mandal S, Saha B, Tripathi A, Differential clinical symptoms among acute phase Indian patients revealed significant association with dengue viral load and serum IFN-gamma level. J Clin Virol2014;61: 365–370. doi: 10.1016/j.jcv.2014.09.00325288310